To validate our proteomic data and to assess whether the expression of PKM2 per se, not just its tyrosine-phosphorylated version, was upregulated in different variants of UC, we carried out Western blotting and immunohistochemical staining using tumor specimens from transgenic and knockout mice, human UC and human UC cell lines. The gene discussed is PKM; the disease is neoplasm.